Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

39 trials with published results (6%)

Research Maturity

301 completed trials (43% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.5%

39 terminated out of 707 trials

Success Rate

88.5%

+2.0% vs benchmark

Late-Stage Pipeline

6%

45 trials in Phase 3/4

Results Transparency

13%

39 of 301 completed with results

Key Signals

39 with results89% success39 terminated

Data Visualizations

Phase Distribution

382Total
Not Applicable (255)
Early P 1 (5)
P 1 (35)
P 2 (42)
P 3 (13)
P 4 (32)

Trial Status

Completed301
Unknown170
Recruiting110
Terminated39
Not Yet Recruiting30
Active Not Recruiting22

Trial Success Rate

88.5%

Benchmark: 86.5%

Based on 301 completed trials

Clinical Trials (707)

Showing 20 of 20 trials
NCT07652294Phase 2Enrolling By Invitation

Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

NCT07012395Phase 2Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

NCT06188793Not ApplicableRecruitingPrimary

Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients

NCT07456566Not ApplicableRecruitingPrimary

Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease

NCT07721207Not ApplicableNot Yet RecruitingPrimary

Ex Vivo Study of hAMSC Secretome in Inflammatory Bowel Disease: Effects on Inflammation and Fibrosis (TARGET)

NCT04757181Not ApplicableCompletedPrimary

The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)

NCT06226883Phase 2RecruitingPrimary

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

NCT03938324Not ApplicableCompleted

Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions

NCT07431606Phase 2RecruitingPrimary

Duloxetine in Inflammatory Bowel Diseases

NCT06571669Not ApplicableRecruiting

BOOM-IBD2 Pivotal Clinical Trial

NCT06956703Recruiting

NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study

NCT06094608Not ApplicableCompletedPrimary

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

NCT06424769Not ApplicableEnrolling By InvitationPrimary

Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management

NCT05809999Not ApplicableCompleted

IBD Neoplasia Surveillance RCT

NCT00606346Active Not Recruiting

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

NCT07520747RecruitingPrimary

A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea

NCT06591013Not ApplicableCompletedPrimary

Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC

NCT06910787Not ApplicableActive Not RecruitingPrimary

Outpatient VR (Virtual Reality)-Brain-gut Behavioral Therapies (BGBT) in Inflammatory Bowel Disease (IBD)

NCT07670975Recruiting

Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)

NCT03285230Active Not Recruiting

The French E3N Prospective Cohort Study

Scroll to load more

Research Network

Activity Timeline